UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
Bank of America Analyst Ratings
Evercore ISI Sticks to Its Buy Rating for Procter & Gamble (PG)
Evercore ISI Adjusts Price Target on Procter & Gamble to $183 From $177, Maintains Outperform Rating
Oppenheimer Adjusts Price Target on Bank of America to $49 From $46, Maintains Outperform Rating
Johnson & Johnson (JNJ) Gets a Buy From RBC Capital
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $167, Maintains Equalweight Rating
Johnson & Johnson Analyst Ratings
Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Raises Price Target to $169
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating
UnitedHealth (UNH) Gets a Buy From Cantor Fitzgerald
Stifel Raises Johnson & Johnson's Price Target to $160 From $155
Exxon Mobil Analyst Ratings
Jefferies Upgrades UnitedHealth to Buy, Cites Growth Outlook
Seaport Global Remains a Buy on Bank of America (BAC)
Exxon Mobil (XOM) Receives a Buy From Morgan Stanley
Piper Sandler Sticks to Its Buy Rating for Exxon Mobil (XOM)
Piper Sandler Reaffirms Their Buy Rating on Chevron (CVX)